Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 356 is a genomic DNA sequence classified as a pseudogene derived from the 5S ribosomal RNA gene family. Unlike the functional 5S rRNA genes—whose products form a critical structural component of the large ribosomal subunit essential for protein synthesis—RNA5SP356 is considered non-functional due to mutations accumulated over evolution that prevent it from participating in ribosome assembly or translation[2][5]. It is annotated in major genomic databases as a non-coding rRNA pseudogene and does not encode for any RNA or protein product with a known cellular function. There is no evidence that RNA5SP356 is expressed, plays a regulatory biological role, or is associated with disease, nor is it targeted by any currently known drugs or therapies[5][6].
None. No drugs target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 356 (RNA5SP356).